Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2001, p. 2631-2634, Vol. 45, No. 9
Department of Microbiology, Toronto Medical
Laboratories and Mount Sinai Hospital,1 and
Department of Laboratory Medicine and Pathobiology, University
of Toronto,2 Toronto, Division of
Infectious Diseases, McMaster University, and Henderson Site, Hamilton
Health Sciences Corporation, Hamilton,3 and
Department of Microbiology, Queen Elizabeth II Health
Sciences Centre, Dalhousie University, Halifax,4
Canada
Received 12 February 2001/Returned for modification 16 April
2001/Accepted 31 May 2001
Analysis of 71 ciprofloxacin-resistant (MIC
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.9.2631-2634.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Interspecies Recombination Contributes Minimally to
Fluoroquinolone Resistance in Streptococcus
pneumoniae
4 µg/ml)
Streptococcus pneumoniae clinical isolates revealed only
1 for which the quinolone resistance-determining regions of the
parC, parE, and gyrB genes
were genetically related to those of viridans group streptococci. Our
findings support the occurrence of interspecies recombination of type
II topoisomerase genes; however, its contribution to the emergence of
quinolone resistance among pneumococci appears to have been minimal.
*
Corresponding author. Mailing address: Department of
Microbiology, Mount Sinai Hospital, 600 University Ave., Room 1483, Toronto, Ontario M5G 1X5, Canada. Phone: (416) 586-4800, ext. 3207. Fax: (416) 586-8746. E-mail: dbast{at}mtsinai.on.ca.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |